Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02712905
Title An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | BEL

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35487 United States Details
Moores UCSD Cancer Center La Jolla California 92093 United States Details
UCLA Medical Center Los Angeles California 90095 United States Details
Northwestern University Chicago Illinois 60208 United States Details
University of Kansas Center for Research, Inc. Kansas City Kansas 66045 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Columbia University New York New York 10027 United States Details
Oregon Health Science University Portland Oregon 97297 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Vanderbilt University Nashville Tennessee 37240 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Institut Jules Bordet Brussel Belgium Details
Netherland Cancer Institute Amsterdam Netherlands Details
VU Medical Center Amsterdam Netherlands Details
Erasmus MC Rotterdam Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field